Skip to content
MBQ Pharma Logo
  • Home
  • Science
  • Team
  • News
  • Contact

FDA Acceptance of IND 148376 for MBQ-167 Phase 1 Study

FDA Acceptance of IND 148376 for MBQ-167 Phase 1 Study

Published On: June 3, 2022-Categories: FDA-
MBQ Pharma Logo

Privacy Policy

The USFDA accepted the IND in June 2022 for the lead candidate MBQ-167 for a Phase 1 study in therapeutic-resistant advanced breast cancer.

©   MBQ Pharma • All Rights Reserved • Website by Flamingo Design

Page load link

Let’s Make Things Happen

  • Home
  • Science
  • Team
  • News
  • Contact
Contact Info

41 Avada Avenue, Florida, 98765

403-904-3623

Unlock Your Online GrowthUnlock Your Online Growth
Go to Top